Cathy McMorris Rodgers - the Chair of the House Energy and Commerce Committee | Official U.S. House headshot
Cathy McMorris Rodgers - the Chair of the House Energy and Commerce Committee | Official U.S. House headshot
House Energy and Commerce Committee Chair Cathy McMorris Rodgers and Subcommittee on Health Chair Brett Guthrie have announced a hearing titled "Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices." In a joint statement, Chairs Rodgers and Guthrie emphasized the importance of engaging with key FDA officials to understand the successes and challenges within the agency. They highlighted the need for transparency to rebuild public trust in government health agencies.
The Subcommittee on Health hearing, scheduled for Wednesday, May 22, 2024, at 10:30 AM ET in the 2322 Rayburn House Office Building, will focus on discussing the FDA's regulation of drugs, biologics, and devices. The hearing will feature testimony from key FDA Center Directors:
- Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research (CDER), Food and Drug Administration
- Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration
- Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health (CDRH), Food and Drug Administration
According to the announcement, the hearing will be open to the public and press, with a live stream available on the House Energy and Commerce Committee's website. For inquiries about the hearing, individuals can contact Emma Schultheis at Emma.Schultheis@mail.house.gov. Press-related questions can be directed to Christopher Krepich at Christopher.Krepich@mail.house.gov.
Alerts Sign-up